AnnaMae ElizaDiehlMD

PubMed

• 1 citations
  PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic...
  Naga Chalasani, Eduardo Vilar-Gomez, Rohit Loomba, Katherine P Yates, Anna Mae Diehl
  Hepatology. 2024-11-01
• Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort.
  Cristian Sanchez-Torres, Ana Ramirez Tovar, Kelsey Chatman, Heather L Morris, Feng Yu
  Hepatology Communications. 2024-11-01
• Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH.
  Jason D Coombes, Paul P Manka, Marzena Swiderska-Syn, Danielle T Vannan, Antonio Riva
  Liver International. 2024-10-18

Journal Articles

• Reply to HEP-12-0274R1  
  Diehl AM, Hepatology, 3/20/2012
• Correlation of Vitamin E, Uric Acid, and Diet Composition with Histologic Features of Pediatric NAFLD  
  Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, Schwimmer JB, Tonascia J, Unalp A, Lavine JE, NASH CRN Research Group, Pediatr Gastroenterol Nutr, 1/1/2012
• Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: the TONIC Randomized Controlled Trial  
  Lavine JE, Schwimmer JB, Van Natta ML, Mosseston JP et al Nonalcoholic Steatohepatitis Clinical Research Networ, JAMA, 4/27/2011
• Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings  
  Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, NASH Clinical Research Network (CRN), Hepatology, 3/1/2011
• Non-alcoholic steatohepatitis pathogenesis: Role of repair in regulating disease progression  
  Jung Y, Diehl AM, Dig Dis, 1/1/2010
• Epithelial-mesenchymal tranisitions and hepatocarcinogenesis  
  Jou J, Diehl AM, J Clin Invest, 1/1/2010
• For the Nonalcoholic Steatohepatitis Clinical Research Network Increased fructose consumption is associated with fibrosis severity in patients with nonalcholoic fatty...  
  Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM, Hepatology, 1/1/2009
• The adventures of sonic hedgehog in development and repair II Sonic hedgehog and live development, inflammation and cancer  
  Omenetti A, Diehl AM, Physiol Gastrointest Liver Physiol, 3/1/2008
• Abnormal exhaled ethane concentrations in scleroderma  
  Cope KA, Solga SF, Hummers LK, Wigley FM, Diehl AM, Risby TH, Biomarkers, 1/1/2006
• Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations  
  Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz P, Magnuson T, Diehl AM, Risby TH, Biomarkers, 1/1/2006
• Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis  
  Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM, Carcinogenesis, 1/1/2006
• What does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons?  
  Tuttle-Newhall JE, Diehl AM, J Hepatol, 1/1/2006
• Cytokines and the pathogenesis of non-alcoholic steatohepatitis  
  Diehl AM, Li ZP, Lin HZ, Yang SQ, Gut, 1/1/2005
• Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide  
  Solga SF, Horska A, Clark JM, Diehl AM, Liver Int, 1/1/2005
• Insulin resistance and steatosis in hepatitis C virus infection  
  Zekry, A, McHutchison JG, Diehl AM, Gut, 1/1/2005
• Recent Events in Alcoholic Liver Disease V Effects of ethanol on liver regeneration  
  Diehl AM, Am J Physiol Gastrointest Liver, 1/1/2005
• Cytokines and the Pathogenesis of NASH  
  Diehl AM. Li Z, Lin H, Yang S, Gut: Recent Advances in Clinical Practice, 1/1/2005
• Arterial Homeostasis, inflammation, and erythropoietic growth factors  
  Goldschmidt-Clermont PJ, Diehl AM, Rev Cardiovasc Med, 1/1/2005
• Should nonalcoholic fatty liver disease be treated differently in elderly patients?  
  Suzuki A, Diehl AM, Nat Clin Pract Gastroenterol Hepatol, 1/1/2005
• Hepatic fibrogenesis requires sympathetic neurotransmitters  
  Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM, Gut, 1/1/2004
• Hematopoietic stem cells convert into liver cells within days without fusion  
  Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ, Nat Cell Biol, 1/1/2004
• Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open laboratory trial  
  Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP, Aliment Pharmacol Ther, 1/1/2004
• Gut flora-based therapy in liver disease?  
  Solga SF, Diehl AM, Hepatology, 1/1/2004
• Fatty liver, hypertension, and the metabolic syndrome  
  Diehl, AM, Gut, 1/1/2004
• Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease  
  Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM, Hepatology, 1/1/2003
• Join now to see all